Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gufic Biosciences has informed that it enclosed the details of meeting with the Analyst/ Institutional Investor scheduled on August 14, 2024. The company has confirmed that the discussion during the meeting will be based on already published information and no Unpublished Price Sensitive Information is proposed to be discussed in this meeting.
The above information is a part of company’s filings submitted to BSE.
